PRA Health Sciences (PRAH) Tops Q1 EPS by 10c

PRA Health Sciences (NASDAQ: PRAH) reported Q1 EPS of $0.41, $0.10 better than the analyst estimate of $0.31. Revenue for the quarter came in at $332 million versus the consensus estimate of $329.8 million.

PRA Health Sciences sees FY2015 EPS of $1.62-$1.72, versus the consensus of $1.41.

For earnings history and earnings-related data on PRA Health Sciences (PRAH) click here.

You May Also Be Interested In

• Tesla touts acceleration of new models, but Q1 results fall short of estimates
• Chubb Corp. (CB) Tops Q1 EPS by 10c
• Weatherford International plc (WFRD) Tops Q1 EPS by 6c